De-SPACed consumer genetics company 23andMe Holding announced that it will redeem all of its outstanding warrants to purchase shares that were issued by VG Acquisition, which took the company public in June.
The redemption deadline for the one-third warrants is Dec. 22 at an exercise price of $11.50 a share for whole warrants. Read more.
